Live from the NIH registry
Studies recruiting near North Las Vegas right now
Top 25 of 453 recruiting studies, sorted by proximity — each links to its official registry page
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
Cleveland Clinic Lou Ruvo Center for Brain Health — Las Vegas, Nevada (8.3 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (8.3 mi)
· Sponsor: Kartos Therapeutics, Inc.
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Relapsing Multiple Sclerosis
Phase 4
Interventional 100 participants sought
Cleveland Clinic — Las Vegas, Nevada (8.3 mi)
· Sponsor: University of Colorado, Denver
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Las Vegas, Nevada (8.3 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Optum Care Cancer Center ( Site 0050) — Las Vegas, Nevada (8.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada (8.3 mi)
· Sponsor: Pfizer
A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old
Healthy Volunteer
Phase 1
Interventional 78 participants sought
PPD Development, LP — Las Vegas, Nevada (8.3 mi)
· Sponsor: Biogen
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
Cleveland Clinic Lou Ruvo Center for Brain Health — Las Vegas, Nevada (8.3 mi)
· Sponsor: Parkinson's Foundation
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (8.3 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Las Vegas, Nevada (8.3 mi)
· Sponsor: TG Therapeutics, Inc.
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
HIV Infections
Phase 1
Interventional 168 participants sought
GSK Investigational Site — Las Vegas, Nevada (8.3 mi)
· Sponsor: ViiV Healthcare
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Major Depressive Disorder (MDD)
Phase 2
Interventional 300 participants sought
Draig Clinical Site — Las Vegas, Nevada (8.3 mi)
· Sponsor: Draig Therapeutics Ltd
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Digestive Disease Specialists - Las Vegas - Crimson Canyon Drive — Las Vegas, Nevada (8.3 mi)
· Sponsor: Eli Lilly and Company
Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults
Antiviral Drug
Phase 1
Interventional 48 participants sought
PPD Las Vegas Clinical Research Unit — Las Vegas, Nevada (8.3 mi)
· Sponsor: Just-Evotec Biologics
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (8.3 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (8.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (8.3 mi)
· Sponsor: NRG Oncology
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1144 — Las Vegas, Nevada (8.3 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Renal Pelvic Denervation Pilot Trial
Uncontrolled Hypertension
N/A
Interventional 60 participants sought
DaVita Clinical Research — Las Vegas, Nevada (8.3 mi)
· Sponsor: Verve Medical, Inc
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Henderson Clinical Trials — Henderson, Nevada (18.2 mi)
· Sponsor: Pfizer
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
Thyroid Eye Disease (TED)
Phase 1, Phase 2
Interventional 135 participants sought
Kriya Clinical Trial Site — Las Vegas, Nevada (8.3 mi)
· Sponsor: Kriya Therapeutics, Inc.
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
Vector Clinical Trials — Las Vegas, Nevada (8.3 mi)
· Sponsor: Eli Lilly and Company
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
University Medical Center of Southern Nevada — Las Vegas, Nevada (8.3 mi)
· Sponsor: Children's Oncology Group
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Acute Stroke, Ischemic Stroke
Phase 2, Phase 3
Interventional 728 participants sought
University Medical Center of Southern Nevada — Las Vegas, Nevada (8.3 mi)
· Sponsor: DiaMedica Therapeutics Inc
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
HER2-positive Advanced Solid Tumor
Phase 1, Phase 2
Interventional 796 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (8.3 mi)
· Sponsor: DualityBio Inc.